Subscribe to RSS
DOI: 10.1055/s-0040-1715857
Pseudotumor Cerebri Caused by SARS-CoV-2 Infection in a Boy
Abstract
In this case report, we present the case of a 7-year-old male patient who started with diplopia and paralysis of the sixth unilateral cranial nerve after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The cranial resonance was normal and the cerebrospinal pressure was 32 cm H2O detected by lumbar puncture. The treatment with corticosteroids and acetazolamide was effective. This is the first case of idiopathic intracranial hypertension associated to SARS-CoV-2 probably due to immune-mediated process.
#
Keywords
pseudotumor cerebri - idiopathic intracranial hypertension - SARS-CoV-2 - Mycoplasma pneumoniaeIntroduction
The neuroinvasive propensity has been reported to be a common feature of infection by coronaviruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19). In fact, neurological symptoms are recognized as a frequent manifestation of COVID-19, caused by direct involvement of the nervous system or activation of an exaggerated immune-mediated response.[1] A study of 214 adult patients with COVID-19 in Wuhan found that 36.4% had neurological symptoms such as acute cerebrovascular disease, headache, dizziness, impaired consciousness, ataxia, or neuropathy.[2]
So far, there are no reported cases of children with neurological disorders secondary to COVID-19, which could be due to underdiagnosis of the infection because children tend to have fewer symptoms or be asymptomatic.
#
Case
A 7-year-old boy consulted for convergent strabismus, blurred vision, and binocular diplopia of 36 hours of evolution without headache, vomiting, or pain with eye movements. The neurological examination revealed the presence of bilateral papilloedema and sixth cranial nerve palsy of left eye. The patient was not obese and the rest of the pediatric and neurological examination was normal. The ophthalmological evaluation revealed increased retinal nerve fiber layer thickness showed in optical coherence tomography (154/151 μm right/left eyes) and normal visual acuity ([Fig. 1]). He had no personal or family history of interest and his neurodevelopment was normal. Up to 3 days before, the patient had suffered a 2-week history of vomiting, cough and fever (maximum temperature 39.2°C), hypogeusia, and hyposmia. Parents had also developed fever and hyposmia.
Magnetic resonance venography imaging was normal. Cerebrospinal fluid (CSF) pressure was 32 cm H2O detected by lumbar puncture after patient sedation. CSF cell count, glucose, protein values, and the study of viruses and bacteria in CSF were normal. Visual-evoked potentials were also normal.
Blood test showed leukocytosis (16.470/μL) without lymphopenia, thrombocytosis (platelets: 1,057,000/μL), hypertransaminasemia (GOT 84 U/L, GPT 90 U/L), and low values of 25-OH vitamin D (16.9 ng/mL). Acute phase reactants were high (C-reactive protein 7.71 mg/dL and ferritin 437 ng/mL). A slight increase in fibrinogen (562 mg/dL) and D-dimer levels (0.82 mg/L) was observed in coagulation analysis.
Polymerase chain reaction (PCR) SARS-CoV-2 from nasopharyngeal simple was negative. Serology blood tests for herpes simplex virus (types 1 and 2), cytomegalovirus, Epstein–Barr virus, Brucella, Borrelia burgdorferi, and Toxoplasma were negative. Both immunoglobulin G (IgG) and IgM of Mycoplasma pneumoniae were positive. Rapid immunochromatographic tests for detection of Ig of SARS-CoV-2 were positive for IgG and negative for IgM.
Chest radiography and echocardiography were normal. Due to the possible coinfection of COVID-19 and M. pneumoniae, oral azithromycin was initiated for 5 days and low molecular weight heparin due to thrombotic risk. When intracranial hypertension was detected, treatment with intravenous methylprednisolone (20 mg/kg/day) was administered for 5 days and oral acetazolamide (20 mg/kg/day) was subsequently started. The evolution was excellent. Strabismus and diplopia was resolved 2 days after starting treatment and no recurrences or other complications have been reported.
#
Discussion
Pseudotumor cerebri (PC) or idiopathic intracranial hypertension is defined as elevated intracranial pressure with normal cerebrospinal composition, neuroimaging studies, and neurological examination (with the exception of sixth cranial nerve palsy).[3]
The association between PC and infections including hepatitis E, hepatitis A virus, measles, and M. pneumoniae has been described, especially in children.[4] This relationship seems to be due to inflammatory process, either primary during acute central nervous system infection or secondary to an immune-mediated process, that cause a dysfunction or the absorptive mechanism of the arachnoids' granulations, ending in decreased central nervous system absorption.[5] These autoimmune mechanisms cause symptoms that appear after active infection, which would justify the negative of our PCR results.
Coinfections of COVID-19 and M. pneumoniae have been described in adult patients.[6] In this case, the presence of prolonged fever together with hyposmia and hypogeusia and the increased C-reactive protein, ferritin, and D-dimer values suggest that this patient had suffered from a SARS-CoV-2 infection that may have been the trigger for PC. This is the first case of PC related to COVID-19.
#
#
Conflict of Interest
None declared.
-
References
- 1 Shi Y, Wang Y, Shao C. et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ 2020; 27 (05) 1451-1454
- 2 Mao L, Jin H, Wang M. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; e201127
- 3 Burkett JG, Ailani J. An up to date review of pseudotumor cerebri syndrome. Curr Neurol Neurosci Rep 2018; 18 (06) 33
- 4 Mosquera Gorostidi A, Iridoy Zulet M, Azcona Ganuza G, Gembero Esarte E, Yoldi Petri ME, Aguilera Albesa S. Pseudotumour cerebri in children: aetiology, clinical features, and progression. Neurologia 2019; 34 (02) 89-97
- 5 Ravid S, Shachor-Meyouhas Y, Shahar E, Kra-Oz Z, Kassis I. Viral-induced intracranial hypertension mimicking pseudotumor cerebri. Pediatr Neurol 2013; 49 (03) 191-194
- 6 Fan BE, Lim KGE, Chong VCL, Chan SSW, Ong KH, Kuperan P. COVID-19 and mycoplasma pneumoniae coinfection. Am J Hematol 2020; 95 (06) 723-724
Address for correspondence
Publication History
Received: 11 June 2020
Accepted: 08 July 2020
Article published online:
02 September 2020
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Shi Y, Wang Y, Shao C. et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ 2020; 27 (05) 1451-1454
- 2 Mao L, Jin H, Wang M. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; e201127
- 3 Burkett JG, Ailani J. An up to date review of pseudotumor cerebri syndrome. Curr Neurol Neurosci Rep 2018; 18 (06) 33
- 4 Mosquera Gorostidi A, Iridoy Zulet M, Azcona Ganuza G, Gembero Esarte E, Yoldi Petri ME, Aguilera Albesa S. Pseudotumour cerebri in children: aetiology, clinical features, and progression. Neurologia 2019; 34 (02) 89-97
- 5 Ravid S, Shachor-Meyouhas Y, Shahar E, Kra-Oz Z, Kassis I. Viral-induced intracranial hypertension mimicking pseudotumor cerebri. Pediatr Neurol 2013; 49 (03) 191-194
- 6 Fan BE, Lim KGE, Chong VCL, Chan SSW, Ong KH, Kuperan P. COVID-19 and mycoplasma pneumoniae coinfection. Am J Hematol 2020; 95 (06) 723-724